Iqbal Z, Rikihisa Y
Department of Veterinary Pathobiology, Ohio State University, Columbus 43210.
J Clin Microbiol. 1994 Jul;32(7):1644-9. doi: 10.1128/jcm.32.7.1644-1649.1994.
We present evidence that supports the carrier status of dogs experimentally infected with Ehrlichia canis after treatment with doxycycline. Canine ehrlichiosis was induced in five dogs by intravenous inoculation with E. canis-infected DH82 cells. All animals developed mild clinical signs of transient fever, body weight loss, thrombocytopenia, and increased gamma globulin levels in plasma. An indirect fluorescent-antibody test (IFA) revealed that all dogs had seroconverted (titer, 5,120) by day 10 postinoculation (p.i.). E. canis was reisolated from blood samples collected at intervals throughout the 2-month period p.i. Doxycycline was administered orally once daily at 10 mg/kg of body weight per day for 1 week starting at 2 months p.i. Following treatment, gamma globulin levels in plasma were decreased. At necropsy on days 54 to 59 after the start of treatment, spleen, liver, kidney, and lymph nodes were collected for E. canis culture and histopathologic examination. Although the dogs did not show significant clinical signs during or after treatment with the antibiotic, E. canis was reisolated from the blood and tissue samples of three of five dogs. A 16-fold reduction in IFA titer was noted in two dogs which were negative for E. canis reisolation at day 49 after the start of treatment, whereas a zero- to fourfold reduction in IFA titer was seen in the remaining three dogs. Western immunoblot reactions to higher-molecular-size E. canis antigens in the sera of two dogs which were negative for E. canis on blood culture decreased, whereas they remained continuously high or only transiently decreased for the duration of the study for antigens in the sera of three dogs from which E. canis was reisolated. Histopathologically, prominent plasmacytosis in the kidney cortex was present in three dogs from which E. canis was reisolated, whereas the kidney cortices of two dogs had moderate to minor plasmacytosis. These findings pose questions regarding the efficacy, dosage and duration of doxycycline treatment in dogs with E. canis infection. In addition, it was shown that IFA and Western immunoblotting may aid in assessing the efficacy of antibiotic therapy when definitive reisolation procedures are not readily available.
我们提供的证据支持了用强力霉素治疗后实验感染犬埃立克体的犬的带菌状态。通过静脉接种感染犬埃立克体的DH82细胞,在五只犬中诱发了犬埃立克体病。所有动物均出现了短暂发热、体重减轻、血小板减少以及血浆中γ球蛋白水平升高等轻度临床症状。间接荧光抗体试验(IFA)显示,所有犬在接种后第10天(p.i.)均发生了血清转化(效价为5,120)。在接种后的2个月期间,每隔一段时间采集血样,均重新分离出了犬埃立克体。从接种后2个月开始,每天口服一次强力霉素,剂量为10 mg/kg体重,持续1周。治疗后,血浆中的γ球蛋白水平降低。在开始治疗后的第54至59天进行尸检时,采集了脾脏、肝脏、肾脏和淋巴结用于犬埃立克体培养和组织病理学检查。尽管这些犬在抗生素治疗期间及之后未表现出明显的临床症状,但在五只犬中的三只犬的血液和组织样本中重新分离出了犬埃立克体。在开始治疗后第49天,两只犬的IFA效价降低了16倍,这两只犬的犬埃立克体重新分离结果为阴性,而其余三只犬的IFA效价降低了0至4倍。对两只血培养中犬埃立克体为阴性的犬的血清中高分子量犬埃立克体抗原的Western免疫印迹反应减弱,而对于三只重新分离出犬埃立克体的犬的血清中的抗原,在研究期间其反应持续保持高水平或仅短暂降低。组织病理学上,三只重新分离出犬埃立克体的犬的肾皮质出现明显的浆细胞增多,而两只犬的肾皮质有中度至轻度的浆细胞增多。这些发现引发了关于强力霉素治疗犬埃立克体感染的疗效、剂量和持续时间的问题。此外,研究表明,当无法轻易进行明确的重新分离程序时,IFA和Western免疫印迹可有助于评估抗生素治疗的疗效。